<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="/resources/xsl/"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>The Oxford Times | Bioline</title>
    <link>http://www.oxfordtimes.co.uk/business/profiles/bioline/</link>
    <description>The Oxford Times /business/profiles/bioline/</description>
    <language>en-gb</language>
    <pubDate>Thu, 18 Mar 2010 13:38:49 +0000</pubDate>
    <lastBuildDate>Thu, 18 Mar 2010 13:38:49 +0000</lastBuildDate>
    <docs>http://www.oxfordtimes.co.uk/business/profiles/bioline/rssterms/</docs>
    <generator>M6</generator>
    <managingEditor>nvincent@newsquest.co.uk (Nigel Vincent)</managingEditor>
    <webMaster>webmaster@digitalmedia.newsquest.co.uk (Tim Joy)</webMaster>
    <image>
        <url>http://www.oxfordtimes.co.uk/resources/images/999282/?type=rsslogo</url>
        <title>The Oxford Times | Bioline</title>
        <link>http://www.oxfordtimes.co.uk/business/profiles/bioline/</link>
    </image>
    <atom:link href="http://www.oxfordtimes.co.uk/business/profiles/bioline/rss/" rel="self" type="application/rss+xml" />
<item>
           <title>On-the-spot diagnostics</title>
           <link>http://www.oxfordtimes.co.uk/business/profiles/bioline/5070298.On_the_spot_diagnostics/?ref=rss</link>
           <description>
  Every day, countless patients around the globe provide specimens for laboratory testing. Invariably, the tests are conducted at a centralised facility and the patient has to return days, or even
  weeks, later to discuss the results and treatment.
</description>
           <pubDate>Thu, 18 Mar 2010 13:33:23 +0000</pubDate>
           <guid isPermaLink="false">b94298a243b45060cca6b300588895f3</guid>
           
    </item>


    <item>
           <title>Credit due</title>
           <link>http://www.oxfordtimes.co.uk/business/profiles/bioline/4786116.Credit_due/?ref=rss</link>
           <description>
  It is said that those who would like to know the value of a little money should try borrowing some. Borrowing money for anything is now pretty tough. The tsunami of credit of a mere 18 months ago
  has subsided and now barely laps at the beach.
</description>
           <pubDate>Thu, 10 Dec 2009 09:00:00 +0000</pubDate>
           <guid isPermaLink="false">6f1568624dbb10fe2cb7abaacbe93d60</guid>
           
    </item>


    <item>
           <title>Versatile inventor</title>
           <link>http://www.oxfordtimes.co.uk/business/profiles/bioline/4738165.Versatile_inventor/?ref=rss</link>
           <description>
  What is the connection between a writer and painter and an inventor of urological devices? Perhaps surprisingly, they are one and the same. Orde Levinson, managing director of Whiz UK, is a
  painter, writes books on art and is an art historian.
</description>
           <pubDate>Fri, 20 Nov 2009 11:20:00 +0000</pubDate>
           <guid isPermaLink="false">b15f1b9aabc793d5260e400fc2af0b07</guid>
           
    </item>


    <item>
           <title>No vein attempts</title>
           <link>http://www.oxfordtimes.co.uk/business/profiles/bioline/4683534.No_vein_attempts/?ref=rss</link>
           <description>
  The windmilling turbines of an aero engine and a device the size of a mobile phone may seem worlds apart, but they are both landmarks in the career of Dr Mark Reeves, founder of MRA Technologies.
</description>
           <pubDate>Thu, 15 Oct 2009 09:56:50 +0100</pubDate>
           <guid isPermaLink="false">b43f2762a073dfe3a061068cfc7d55b8</guid>
           
    </item>


    <item>
           <title>Homeopathy test</title>
           <link>http://www.oxfordtimes.co.uk/business/profiles/bioline/4649864.Homeopathy_test/?ref=rss</link>
           <description>
  Homeopathy is an alternative treatment discovered more than 200 years ago by Dr Samuel Hahnemann, a gifted and multilingual doctor and scientist born in Mannheim, Germany.
</description>
           <pubDate>Fri, 25 Sep 2009 14:45:41 +0100</pubDate>
           <guid isPermaLink="false">01ba903fbea37bc9853bc089f4dee062</guid>
           
    </item>


    <item>
           <title>Test targets TB</title>
           <link>http://www.oxfordtimes.co.uk/business/profiles/bioline/4555832.Test_targets_TB/?ref=rss</link>
           <description>
  Biotechnology is a high-risk industry, where companies enjoy varying degrees of success. Some exhibit solid performance, others bump along, to either disappear or be acquired by their rivals. But
  the sector has a good sprinkling of stars, too.
</description>
           <pubDate>Thu, 20 Aug 2009 10:14:29 +0100</pubDate>
           <guid isPermaLink="false">3aac4084c41d94fb651365ce15cd9aec</guid>
           
    </item>


    <item>
           <title>Funding growth</title>
           <link>http://www.oxfordtimes.co.uk/business/profiles/bioline/4496314.Funding_growth/?ref=rss</link>
           <description>
  As a target for investors, biotechnology has always had something of a roller-coaster ride. Unattractive in the mid-1980s, the sector bounced back to become the gold rush of the 1990s, alongside
  the dotcoms.
</description>
           <pubDate>Thu, 16 Jul 2009 11:00:07 +0100</pubDate>
           <guid isPermaLink="false">3c7b1f438859c530c59a1232e11b2e3d</guid>
           
    </item>


    <item>
           <title>A fertile idea</title>
           <link>http://www.oxfordtimes.co.uk/business/profiles/bioline/4446585.A_fertile_idea/?ref=rss</link>
           <description>  Arriving at a crossroads reached by many in the past and doubtless many in the future, Toni Ertl had a stark choice. Faced with unemployment when Oxford Bio-Innovation closed in 2008, he could look
  for a new job, or go it alone. He chose the latter.
</description>
           <pubDate>Thu, 18 Jun 2009 15:43:01 +0100</pubDate>
           <guid isPermaLink="false">193a95eaea82694ec0ac1746448fbbe5</guid>
           
              <enclosure url="http://www.oxfordtimes.co.uk/resources/images/948839/" type="image/jpeg" />
           
    </item>


    <item>
           <title>Search for diagnosis</title>
           <link>http://www.oxfordtimes.co.uk/business/profiles/bioline/4369244.Search_for_diagnosis/?ref=rss</link>
           <description>
  In today’s economic climate, there are plenty of horror stories of company failures and closures. But you do not have to go too far to find some good news in the bioscience community, at least to
  the door of Oxford Gene Technology, which has just acquired Sense Proteomic, to significantly boost its area of expertise.
</description>
           <pubDate>Thu, 14 May 2009 13:57:19 +0100</pubDate>
           <guid isPermaLink="false">8e1f43b16c57055305e09a9e2635d179</guid>
           
    </item>


    <item>
           <title>Surgery in a spin</title>
           <link>http://www.oxfordtimes.co.uk/business/profiles/bioline/4295388.Surgery_in_a_spin/?ref=rss</link>
           <description>
  Silk was first discovered by the Chinese around 3000BC. From the very beginning, its main use has been in textiles, but there is some evidence of early warriors using it to sew up their battle
  wounds.
</description>
           <pubDate>Thu, 16 Apr 2009 11:19:38 +0100</pubDate>
           <guid isPermaLink="false">d2545a6d7085150c2adde67e442f198f</guid>
           
    </item>
  </channel>
</rss>